Literature DB >> 11432236

Total mesorectal exsicion (TME).

R J Heald.   

Abstract

For almost twenty years the concept of total mesorectal excision (TME) has featured in the medical literature. It remains however the object of ongoing controversy and sometimes of downright antagonism. At the present time there are at least four other names for exactly the same technique being championed by different authorities. 1. Circumferential Mesorectal Excision (Enker); 2. Sharp Mesorectal Excision (Cohen); 3. Extrafascial Excision of the Rectum (Hill); 4. Total Anatomical Dissection (Boley). As Shakespeare said "A rose by any other name would smell as sweet".

Mesh:

Year:  2000        PMID: 11432236

Source DB:  PubMed          Journal:  Acta Chir Iugosl        ISSN: 0354-950X


  8 in total

1.  Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases.

Authors:  Zong-Guang Zhou; Zhao Wang; Yong-Yang Yu; Ye Shu; Zhong Cheng; Li Li; Wen-Zhang Lei; Tian-Cai Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 2.  Anatomy of the lateral ligaments of the rectum: a controversial point of view.

Authors:  Guo-Jun Wang; Chun-Fang Gao; Dong Wei; Cun Wang; Wen-Jian Meng
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

3.  Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer.

Authors:  Z-G Zhou; M Hu; Y Li; W-Z Lei; Y-Y Yu; Z Cheng; L Li; Y Shu; T-C Wang
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

4.  Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer.

Authors:  Hilke Vorwerk; Thorsten Liersch; Hilka Rothe; Michael Ghadimi; Hans Christiansen; Clemens Friedrich Hess; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

5.  Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation.

Authors:  Atilla Kurt; Fatih Yanar; Oktar Asoglu; Emre Balik; Vakur Olgac; Hasan Karanlik; Sevda Tanrikulu Kucuk; Evin Ademoglu; Gulcin Yegen; Dursun Bugra
Journal:  BMC Clin Pathol       Date:  2012-12-31

6.  Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial.

Authors:  Stephanie E Combs; Meinhard Kieser; Daniel Habermehl; Jürgen Weitz; Dirk Jäger; Piero Fossati; Roberto Orrechia; Rita Engenhart-Cabillic; Richard Pötter; Manjit Dosanjh; Oliver Jäkel; Markus W Büchler; Jürgen Debus
Journal:  BMC Cancer       Date:  2012-04-03       Impact factor: 4.430

7.  Laparoscopy-assisted posterior low anterior resection of rectal cancer.

Authors:  Hao Qu; Yan-Fu Du; Min-Zhe Li; Yu-Dong Zhang; Jian Shen
Journal:  BMC Gastroenterol       Date:  2014-09-12       Impact factor: 3.067

8.  Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.

Authors:  Henriette Quack; Luise Erpenbeck; Hendrik A Wolff; Thilo Sprenger; Cornelia S Seitz; Michael P Schön; Steffen Neumann; Kathrin Stanek; B Michael Ghadimi; Beate Michels; Peter Middel; Inga-Marie Schaefer; Torsten Liersch; Lena-Christin Conradi
Journal:  Case Rep Oncol       Date:  2013-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.